Bayer AG is a life science company. The company's segments are pharmaceuticals, consumer health, crop science, and animal health.

In 2018, Bayer acquired the multinational corporation, Monsanto, as well as their entire activity in Israel and former subsidiaries. The company operates through Bayer Israel, a fully owned subsidiary, where pharmaceutical, consumer health and crop science divisions operate, and through a Bayer crop science site where R&D and breeding activities in vegetable seeds take place.

Bayer AG is also scouting for Israeli technologies in the fields of pharma, agriculture, and now digital health technologies.

In 2022, Bayer announced the opening of Cyber Security Innovation Lab, known as the "Digital Hub," located in the tech hub of Israel. The purpose of the Digital Hub is to bring together innovation and expertise in the field of cybersecurity. The team of experts at the Digital Hub will rigorously test and evaluate the latest security solutions to guarantee that only the most reliable options are made available to the market. Bayer believes in a data-driven approach to cybersecurity and is dedicated to providing businesses and organizations with the necessary tools and resources to protect their valuable information. With the opening of the Cyber Security Digital Hub, Bayer continues to demonstrate its commitment to advancing the field of healthcare and improving lives worldwide.